Selection of Recent Oncology Articles Published in The Lancet

On this page, you will find links to the latest oncology-related research articles published in The Lancet.

Filter

Date Title Topic
16 Jul 2016 STAMPEDE trial and patients with non-metastatic prostate cancer Prostate Cancer
23 Aug 2016 Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-... Anti-Cancer Agents & Biologic Therapy , Head and Neck Cancers
28 Nov 2016 Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blin... Anti-Cancer Agents & Biologic Therapy , Breast Cancer, Metastatic
12 Dec 2016 Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised c... Cancer Immunology and Immunotherapy , Non-Small-Cell Lung Cancer, Metastatic
04 Sep 2016 Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastas... Non-Small-Cell Lung Cancer, Metastatic , Supportive Care
07 Dec 2016 Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, mult... Cancer Immunology and Immunotherapy , Urothelial Cancers
25 Jun 2016 Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis Cancer Aetiology, Epidemiology, Prevention
13 Jun 2016 Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle... Anti-Cancer Agents & Biologic Therapy , Lymphomas
09 Jun 2016 Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Anti-Cancer Agents & Biologic Therapy , Sarcoma
02 Jun 2016 Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) Anti-Cancer Agents & Biologic Therapy , Pancreatic Cancer
11 Apr 2016 Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial Anti-Cancer Agents & Biologic Therapy , Lymphomas
11 Mar 2016 Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial Anti-Cancer Agents & Biologic Therapy , Ovarian Cancer
09 Mar 2016 Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomis... Anti-Cancer Agents & Biologic Therapy , Cancer Immunology and Immunotherapy , Non-Small-Cell Lung Cancer, Metastatic
08 Mar 2016 Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomis... Anti-Cancer Agents & Biologic Therapy , Renal Cell Cancer
06 Mar 2016 Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chem... Anti-Cancer Agents & Biologic Therapy , Urothelial Cancers